ASX: Australian stocks are expected to slide in the stock market after a rough night for US markets, with futures falling 77 points to 8:10 a.m. AEDT

The S&P / ASX200 Reference Index closed 44 lower1 points, or 065 percent, to 67806 on Wednesday, while the All Ordinaries closed 512 points, or 072 percent, at 70602

Wall Street: US stocks had their worst day in three months on Wednesday local time as wild moves in GameStop stock caught attention. Furthermore, investor sentiment fell after the Federal Reserve kept rates near zero / p>

The Dow Jones Industrial Average fell 205 percent to 3030317 the S&P 500 lost 257 percent to 375077 and the Nasdaq Composite fell 261 percent to 1327060

GameStop: It’s the word of the day, but what on earth is wrong with GameStop stock? It is a stock market spectacle that the famous fund manager Michael Burry described as “unnatural, crazy and dangerous”

Others have described it as the “nerds on Wall Street” battle, and even Elon Musk has something to say. And some student loan investors are betting that they can use their profits to wipe off their debts

Businesswoman’s win of 280$ 000: An Australian businesswoman found 280 in a defamation case against a large Australian publicationWon $,000 after ending an “offensive mockery” This is what happened:

Microsoft’s Forecast: Microsoft CEO Satya Nadella said the company had become a major player in the cybersecurity space This is a good thing given the “big crisis” the world is currently facing in cybersecurity

“Most dangerous in the world”: A group of countries has successfully shut down the Emotet hacking network, which has been dubbed “the most dangerous in the world” Here’s why Emotet was so bad

Warning from BlackRock: Larry Fink is the head of the world’s largest wealth manager, BlackRock, and in his latest annual letter to CEOs, Fink warned that high-pollution companies that do not switch to clean energy will face major obstacles invest That’s what he said

Credit Score: Your ability to get a home loan can decrease to this number So why do only 7 percent of Australians actually know their credit score? Here’s what you need to know:

Borders: And Queensland will start on Jan. February Open Its Borders To NSW As Australia’s Zero Community Broadcasting Continues, Premier Annastacia Palaszczuk calls this great news for tourism companies

“It’s a great time for family reunification but also for people planning their vacations. I met with tourism companies yesterday, they are really feeling it at the moment,” she said

Take control of your money and learn to maximize it with the women’s money movement! Join the club on LinkedIn and follow Yahoo Finance Australia on Facebook, Twitter and Instagram

A German court will announce its verdict on Thursday in the trial against a neo-Nazi who is accused of murdering the politician who promotes migration, Walter Luebcke This murder shocked the country and highlighted the growing threat of right-wing extremism

Avec le contrat guarantee Obsèques Macif, vous êtes accompany au moment du décès et après les obsèques (under conditions)

According to IDC, smartphone vendors shipped a total of 3859 million devices in the third quarter of 2020, a 43% increase over the prior-year quarter

Investors stare at their biggest loss on the ASX since September after Federal Reserve worries over the US economy tumbled the markets

The remains of the Placement Privilégié des Français Soucieux de Se Constituer un Patrimoine Les placements alternatifs peuvent avoisiner les 850% de

Welcome to Accuray’s conference call to review financial results for the second quarter of fiscal year 2021, which commences on Jan. December 2020 ended Josh Levine, President and Chief Executive Officer of Accuray, joining us today Shig Hamamatsu, Senior Vice President and Chief Financial Officer, Accuray; and Suzanne Winter, Chief Commercial Officer and Senior Vice President of R&D at Accuray

One week after the start of the employment relationship, US President Joe Biden clearly warned Beijing against expansionary intentions in East and Southeast Asia

Facilitez-vous la vente et gagnez un temps précieux en optant pour la reprise de votre véhicule actuel par votre concessionnaire en quelques étapes

Kelly Grove Racing unintentionally took a quick look at Andre Heimgartner’s 2021 livery in an Instagram post

Jagran New Media has selected Triton Digital to drive the distribution and monetization of its podcast content

With over 30 players proactively involved in developing novel therapies for non-muscle invasive bladder cancer (NMIBC) and over 30 therapies expected to roll out, the non-muscle invasive bladder cancer pipeline offers a promising big picture for the next DecadeLos Angeles, USA, Jan 27, 2021 (GLOBE NEWSWIRE) – Pipeline Analysis for Non-Muscle-Invasive Bladder Cancer Reveals Tremendous Growth Opportunities for Years to Come With over 30 players proactively involved in developing novel therapies for Non-Muscle-Invasive Bladder Cancer (NMIBC) and over 30 therapies Expected Non-Muscle-Invasive Bladder Cancer Pipeline Offers a Promising Big Picture for the Next Decade DelveInsight’s “NMIBC Pipeline Insight for Non-Muscle-Invasive Bladder Cancer, 2021” details the NMIBC pipeline scenario, unmet need, and therapeutic assessment Highlighted Key Pipeline Therapies for Non-Muscle-Invasive Bladder Cancer Some of the key highlights of the non-muscle-invasive bladder cancer pipeline: 30 key companies including APIM Therapeutics, UroGen Pharma, Pfizer, AstraZeneca, TARIS Biomedical, Bristol-Myers Squibb, Ono Pharmaceuticals, Janssen Pharmaceuticals and several others are increasing in value ng pipeline for non-muscle invasive bladder cancer involved 30 new therapies are in the NMIBC pipeline at various stages of clinical development including ATX-10, Imfinzi, TAR-200, Sasanlimab, Balversa, UGN-102, Opdivo and several others while underway ATX-101 and TAR-200 are in the early stages of clinical development (ATX-101 in preclinical stages and TAR 200 in phase I); UGN-102 and Balversa are in the phase II of studies with Opdivo and PF-06801591 in the final stage (phase III) of clinical development Anchiano Therapeutics is using its know-how in the development of small-molecule oncology and is developing novel small-molecule inhibitors in collaboration with ADT Pharmaceuticals of RAS and PDE10 / β-Catenin LIPAC works to improve the therapeutic index of proven cancer drugs, leading to more effective treatments for intracavitary cancers with the help of its proprietary paclitaxel proliposomal intracavity drug delivery platform, LiPax, LIPAC announced the successful completion of a clinical phase -2A marker lesion study known to predict long-term recurrence-free survival rates (two years) in patients with low-grade, highly recurrent NMIBC treated with LiPax In August 2020, GeneCentric Therapeutics entered into a research partnership with Janssen r RNA-Based Biomarkers of Drug Responses in Non-Muscle-Invasive Bladder Cancer Non-muscle-invasive bladder cancer is a common, heterogeneous cancer found in the tissues of the inner surface of the bladder that does not involve the bladder muscle. NMIBC Pipeline Therapies Opdivo: Bristol -Myers Squibb / Ono Pharmaceuticals Opdivo (Nivolumab) is a programmed immune checkpoint inhibitor for Death 1 (PD-1) developed by Bristol-Myers Squibb.The drug uses the body’s immune system to restore the anti-tumor immune response by it blocks the interaction between PD-1 and its ligands Opdivo plays an important role as a treatment option for multiple cancers It has been approved for colorectal cancer; Stomach cancer; Head and neck cancer; Hodgkin’s disease; Liver cancer; Malignant melanoma; Mesothelioma; Non-small cell lung cancer; Renal cell carcinoma; Urogenital cancer and is currently in phase III clinical development for participants with high-risk non-muscle invasive bladder cancer who will be treated with BCG in a phase III study entitled “A phase III randomized, double-blind study of nivolumab in combination with intravesical BCG versus standard BCG alone (NCT04149574) The study is currently in the recruitment phase with an estimated number of 700 participants and is expected to be completed in August 2030. BMS is also evaluating Opdivo in a phase II study entitled “ A randomized, open-label Phase II study of nivolumab or nivolumab / BMS-986205 alone or in combination with intravesical BCG in participants with BCG-unresponsive high-risk non-muscle invasive bladder cancer ”(NCT03519256) The study is currently in the recruitment phase with a estimated number of 358 attendees and is expected in September To be completed in 2024 UGN-102: UroGen Pharma UGN-102 (Mitomycin Gel) is an investigational formulation that uses the innovative RTGel Reverse Thermal Hydrogel technology to treat low-grade NMIBC, UroGen Pharma is investigating phase 3 therapy to ensure long-term efficacy and safety of UGN-102 (mitomycin) for an intravesical solution with or without (±) transurethral resection of bladder tumors to be assessed The study is currently in the recruitment phase with an estimated number of 632 participants and is expected to be completed in December 2023 Atezolizumab: Atezolizumab ( Tecentriq) from Hoffmann-La Roche Roche, a monoclonal antibody developed to bind to a protein called PD-L1, which is expressed on tumor cells and tumor-infiltrating immune cells, is already commercially available for breast cancer Liver cancer; Malignant melanoma; Non-small cell lung cancer; Small cell lung cancer; and Urogenital Cancer Roche is also evaluating the drug for non-muscle invasive bladder cancer.It is currently in the recruitment phase with an estimated enrollment of 614 participants and is expected to be completed in February 2028. To learn more about NMIBC drug development, request a sample report for the NMIBC drug pipeline Scope of Non-Muscle Invasive Bladder Cancer Pipeline Report Coverage: Global Major Players: 30 Companies Key Players: Bristol-Myers Squibb, Ono Pharmaceuticals, Pfizer, Merck Sharp & Dohme Corp., Ferring Pharmaceuticals, UroGen Pharma, Roche, Viventia Bio, ImmunityBioKey Drugs: 30 pipeline drugsNon-muscle invasive bladder cancer therapies: Atezolizumab, ALT-803, UGN-102, Vicinium, Nivolumab, Pembrolizumab, NMC-06801591, non-muscle therapies Blasenkrebstalizumab, PF-06801591 Late-stage (Phase III) (Phase II) NMIBC therapies (Phase I) Non-muscle invasive bladder cancer therapies Pre-clinical candidates Inactive candidates and discovery candidates for non-muscle invasive bladder cancer Targets Protease immune system Multiple kinase and other mechanism of action Protease inhibitor Immunomodulatory multiple kinase inhibitor Antioxidants Immunomodulatory multiple kinoplastic anti-inflammatory drugs immunomodulatory multiple kinoplastic drugs anti-inflammatory immunomodulatory therapies AntibodiesNanoparticlesOncolytic VirusesPeptidePlasmidProteinSmall MoleculeLigandBacteria and other Route of Administration InfusionIntradermalIntravenousIntravesicalOralOther types of products MonoCombination Mono / Combination Visit us, to learn more about the reporting offerings How many non-muscle invasive bladder cancer drugs are developed by each company? How many emerging drugs are in the middle and late stages of development for the treatment of non-muscle invasive bladder cancer? What are the most important collaborations? (Industrial-industry, industrial-science), mergers and acquisitions, licensing activities in connection with non-muscle-invasive bladder cancer therapeutics? What current trends, drug types, and novel technologies have been developed to overcome the limitation of existing therapies? Clinical trials of non-muscle invasive bladder cancer and its status? Key names given to new medicines? Contact our Business Executive @ NMIBC Pipeline Trends and Futuristic Outlook to learn more about the domain. Table of Contents 1Introduction2Executive Summary3Non-Muscle Invasive Bladder Cancer: Overview4NMIBC Pipeline Therapeutics5Therapeutic Assessment6Non-Muscle Invasive Bladder Cancer – Delve-nasonive Commercial Collaboration8Insighted Analytical Perspective7In-Deep Commercial Collaboration Products8 Products at Discovery Stage13NMIBC Inactive Products14Non-Muscle Invasive Bladder Cancer Key Companies15Non-Muscle Invasive Bladder Cancer Key Products16NMIBC Unsatisfied Need17NMIBC Future Perspectives and Conclusions18Analyst Views on NMIBC Future Trends19Appendix20 About DelveInsight, The United States ‘Bladder Cancer Market Market Report Provides Detailed Understanding, 30 Related Reports, Detailed Understanding Of The Bladder Cancer Market Report, 30 About DelveInsight, The United States’ Detailed Understanding Of The Bladder Cancer Market Report , EU5 (Germany, p Pain, Italy, France and UK) and Japan Muscle Invasive Bladder Cancer Market DelveInsights report, “Muscle Invasive Bladder Cancer Market Insights, Epidemiology, and Market Forecast 2030” provides a detailed understanding of Muscle Invasive Bladder Cancer, historical and predicted epidemiology, as well as Noninvasive Bladder Cancer Market Bladder Cancer DelveInsights report “Non-Muscle Invasive Bladder Cancer (NMIBC) – Market Insights, Epidemiology and Market Forecast – 2030” provides a detailed understanding of NMIBC, historical and forecast epidemiology as well as NMIBC market trends in the United States, the EU5 (Germany, Spain, Italy, France and the UK) and Japan Multiple Myeloma Market DelveInsights report ‘Multiple Myeloma (MM) Market Insights, Epidemiology and Market Forecast – 2030’ provides a detailed understanding of MM, historical and forecast epid emiology as well as the MM market trends in US, EU5 (Germany, France, Italy, Spain and UK), Japan and China Non-Small Cell Lung Cancer Market DelveInsights Report on Market Insight, Epidemiology, and Market Forecast for Non-Small Cell Lung Cancer (NSCLC) – 2030 Provides Detailed Understanding of Non-Small Cell Lung Cancer and Historical and Predicted Epidemiology as Market Trends for Non-Small Cell Lung Cancer in the US, EU5 (Germany, France, Italy, Spain and UK) and Japan Prostate Cancer Market DelveInsights Report “Prostate Cancer Market Insights, Epidemiology and Market Forecast 2030 “Provides a detailed understanding of prostate cancer, historical and forecast epidemiology, and trends in prostate cancer market in US, EU5 (Germany), Spain, Italy, France and UK) and Japan Adenoid Cystic Carcinoma Market DelveInsights Report” M. Arket Insights, Epidemiology, and Market Forecast for Adenoid Cystic Carcinoma – 2030 “provides a detailed understanding of Adenoid Cystic Carcinoma, historical and forecast epidemiology, and market trends for Adenoid Cystic Carcinoma in the US, EU5 (Germany, Spain, Italy, France and the UK ) and Japan Advanced Liver Cancer Market DelveInsight’s “Advanced Liver Cancer Market Insights, Epidemiology and Market Forecast-2030” report provides a detailed understanding of advanced liver cancer, historical and forecast epidemiology, and advanced liver cancer market trends in the United States, EU5 ( Germany, Spain, Italy, France and United Kingdom) and Japan Advanced Pancreatic Cancer Market DelveInsight’s “Advanced Pancreatic Cancer Market Insights, Epidemiology and Market Forecast-2030” report provides a detailed understanding of Advanced Pancreatic Cancer, the histor pancreatic adenocarcinoma market DelveInsights report, “Pancreatic Adenocarcinoma – Market Insights, Epidemiology, and Market Forecast 2030” provides us, EU5 (Germany, Spain, Italy, France and United Kingdom) and Japan Advanced Pancreatic Cancer market trends and forecast epidemiology a detailed understanding of pancreatic adenocarcinoma, historical and predicted epidemiology, and market trends for pancreatic adenocarcinoma in the US, EU5 (Germany, Spain, Italy, France and UK) and Japan About DelveInsight DelveInsight is a leading management consulting and research company operating Focuses solely on the life sciences It supports pharmaceutical companies with comprehensive solutions to improve their performance Our subscription-based platform PharmDelve gives you easy access to all market research reports on healthcare and pharmaceuticals CONTACT: K Contact us: Shruti Thakur info @ delveinsightcom 1 (919) 321-6187 DelveInsight

Ed Jones, who will drive the Dale Coyne Racing with Vasser Sullivan-Honda in this year’s IndyCar championship, is confident that he can get up to speed quickly on ovals

New COVID-19 cases have urged the Maori Party to stay away from the political events in Waitangi this year

As negotiations continue over the government’s media code, the competition watchdog has released a report showing Google’s dominance of the $ 3b ad space

Sillonnez la ville avec une autonomie 100% électrique de 52km ou partez à l’aventure avec une autonomie hybrid allant jusqu’à 677km

Tesla Motors reported its first annual profit on Wednesday after a sharp spike in car deliveries despite the upheaval in the coronavirus pandemic, as it signaled confidence in more growth in 2021

LENEXA, KANSAS, Jan 27, 2021 (GLOBE NEWSWIRE) – Digital Ally, Inc, (NASDAQ: DGLY) (the “Company”), which develops, manufactures and markets advanced video recording products and other key security products for law enforcement, emergency management, fleet security and security, announced today that it has entered into a security purchase agreement with institutional investors the issue and sale of 14300000 common shares (subject to the direct sale of common shares of the Company and pre-funded warrants that may be issued to investors who would otherwise advantageously own more than 999% of the Company’s outstanding common shares (if common shares issued) and warrants to purchase up to 14300000 common shares priced at $ 280 per share and associated warrant for a total of 40 gross proceeds040$ 000 in a registered direct offer at market price under Nasdaq rules. The warrants have an exercise price of $ 325 per share and are immediately exercisable and expire five years after the issue date Kingswood Capital Markets, Division of Benchmark Investments, Incacts as the exclusive placement agent for the offer Completed February 2021, provided the usual closing conditions are met The offer is made in accordance with an effective shelf registration declaration on Form S-3 (file number 333-239419), which was previously filed on 25 Filed with the Securities and Exchange Commission (“SEC”) on June 2, 2020 The offer of the common stock and its warrants, as well as the pre-funded warrants and warrants, will be made only by means of a prospectus, including a prospectus addendum, which is part of the effective registration statement and the terms of the proposed offer, which is filed with the SEC The Company will also file a Form 8-K in connection with the securities purchase agreement and the completion of the offer.This press release does not constitute an offer to sell or the solicitation of an offer to buy, nor will there be any sale of these securities in any country in which in which any such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of that jurisdiction. If available, copies of the prospectus supplement to this registered direct offer are to be found along with de Available in the related prospectus on the SEC’s website at www.sekGovernment or from Kingswood Capital Markets, a division of Benchmark Investments Inc, 17 Battery Place, Suite 625, New York, NY 10004, Attention: Syndicate Department or email syndicate @ kingswoodcmcom or call (212) 404-7002 Before investing in this offering, interested parties should review the Supplement and the Please read the attached prospectus and the other documents the Company has filed with the SEC and which are incorporated by reference into this Supplement and the accompanying prospectus and which contain further information about the company and any such offer About Digital Ally Digital Ally® Headquartered in Lenexa, KS, specializes in the development and manufacture of high quality video recording equipment, video analysis software, disinfectants and related security products.Digital Ally pushes the boundaries of technology in industries such as law enforcement, emergency management, fleet security, security products and Digita’s complete product solutions l Ally include vehicle and body cameras, flexible software storage, automatic recording technology, and various critical security products.These products work seamlessly together and are easy to install and use.In addition, Digital Ally launched virus response product lines including a non-contact thermometer / device with controlled Accessed under the company’s ThermoVu ™ brand and a Category IV disinfectant / disinfectant from the EPA under the company’s Shield ™ brand. The company recently launched its line of Shield PPE products, including electrostatic sprayers, masks and Digital Ally gloves -Products are sold by domestic direct sales reps and international dealers worldwide For more news and information, visit wwwdigitalinccom or follow additional Digital Ally, Inc Social media channels here: Facebook I Instagram I LinkedIn I Twitter Contact information Stanton Ross, CEO Tom Heckman, CFO Digital Ally, Inc 913-814-7774 info @ digitalallyinccom Forward-Looking Statements This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Act of 1934. These forward-looking statements are based largely on expectations or projections of future events that could be due to inaccurate assumptions and are subject to various business risks and known and unknown uncertainties, some of which are beyond the control of management.As a result, actual results could differ materially from the forward-looking statements contained in this press release. A variety of factors could cause actual results to differ materially The forward-looking statements include, but are not limited to, the Company’s ability to complete the financing, the intended use of the proceeds, the Un company, its ongoing Nasdaq listing requirements or standards, competition from larger, more established companies with far greater economic and human resources, its ability to attract and retain customers and quality employees, the effects of changing economic conditions and changes in government regulations, Tax Rates and Similar Matters These cautionary statements should not be construed as being exhaustive or as an admission as to the reasonableness of the company’s information.The company cannot predict or determine any factors that would cause actual results to differ materially from those in the forward-looking statements or statements Other statements indicated may differ. Readers should consider statements including the words “believes,” “expects,” “anticipates,” “intends,” “estimates,” “plans,” “projects,” “should” or other expressions The company does not undertake to publicly update or revise any forward-looking statements as a result of new information, future events or for any other reason or further information on factors that the company may make and that could materially affect its operations are included on the shelf registration statement on Form S-3 (file number 333-239419) filed with the Securities and Exchange Commission

(Bloomberg) – WallStreetBets, the internet forum that is upsetting retailers, briefly reached out to new users on Wednesday after a flood of new subscribers raised concerns about the ability to monitor content, a note said on The WallStreetBets home page was closed to all users for just over an hour on Wednesday evening in New York City A message posted on the site just after 6:30 p.m. New York had technical difficulties due to a flood of new members, so moderators “didn’t Able to ensure Reddit’s content guidelines, the forum returned as usual an hour later, and the moderators pinned a post that said its rapid growth made it difficult to oversee the site had gained more than 3 million members when it did Daytrader company owned by GameStop Corp. to AMC Entertainment Holdings IncThis led to massive rallies that burned hedge funds that had sold the stocks short.In a similar drama that unfolded at the same time, the Discord communications platform banned WallStreetBets for allowing “hateful and discriminatory content after repeated warnings” according to repeated warnings Step, though much smaller, resulted in similar bans on tech companies for violating policies, including removing former President Donald Trump from Twitter and Amazoncom’s AWS removing social media site Parler from their servers, in response to the brief outage at WallStreetBets The site’s quick and painful stocks of quick and painful GameStop, which had quintupled fivefold in three days, fell as much as 37% before reducing the loss, while AMC, which doubled in Wednesday’s cash session, fell at one point more than 50% before it halved Nokia that one The current cell phone giant, which gained 38% in regular trade, gave up more than a third of that before recovering and down 6%Wider gauges didn’t seem to be affected by the excitement, futures on the Nasdaq 100 index stayed about 0.4% lower, weighed down by Tesla IncBad earnings report and mediocre results at Apple Inc. and Facebook IncThe day trading phenomenon landed in Washington on Wednesday when the White House press secretary told U.S Treasury Secretary Janet Yellen and the Biden administration economics team monitor stock market activity surrounding GameStop and other severely curtailed businesses Federal Reserve Chairman Jerome Powell dodged questions at his regular press conference on the subject, Senator Elizabeth Warren weighed in, saying she wanted to Ensuring Securities Regulators “Wake Up And Do Their Job Not long after that, the Securities and Exchange Commission announced that it was” actively monitoring “volatility in the options and stock markets. Before the subreddit was taken private, there were 5 million members of 3, according to the website r / wallstreetbets That’s nearly 1, according to Breakout Point, a data and analytics company, it’s 5 million more users than it was a week ago, and new followers started flooding copycat message boards almost immediately on Reddit, a forum called WallStreetBetsNew, and last year was founded, rose to almost 200000 users, from around 71000 earlier in the dayFor more articles like this, please visit us on BloombergcomSubscribe Now to stay ahead of the game with the most trusted business news source © 2021 Bloomberg LP

What happened? Shares in Advanced Micro Devices (NASDAQ: AMD) fell 62% on Wednesday following the chipmaker’s fourth-quarter financial results announcement, AMD’s revenue rose 53% year over year to $ 3

(Bloomberg) – Asian stocks fell U onS. Stock futures, disappointing gains from tech giants, fueled valuation concerns The dollar extended its advance S&P 500 futures slipped on results from Apple Inc. and Tesla Inc sent stocks after the market slide stocks fell in Japan, South Korea and AustraliaS. Benchmark plummeted 26% – most since October – after Federal Reserve officials left their main interest rate unchanged and made it clear that the central bank was nowhere near massive support for the economy, and ten-year government bond yields stabilized and rose a little over 1% tradedThe turmoil continued in the pockets of the market where retailers are becoming a dominant force in GameStop Corp. stocks and AMC Entertainment Holdings Inc fell after the market, reducing the surge on Wednesday The WallStreetBets Reddit forum, which fueled the retail frenzy, was previously briefly privatized by moderators, a surge in stocks reversed this week as investors searched for a series of earnings releases to order Get advice on corporate health Fed Chairman Jerome Powell told a news conference that the US. The economy was far from full recovery and still missed policymakers’ inflation and employment targets. “Markets have been vulnerable to setback given some of the positional and sentiment data we have monitored, but we still believe we have a strong one experience economic and profitable recovery, “said Peter Oppenheimer, Chief Global Equity Strategist at Goldman Sachs Group Incsaid on Bloomberg TV, “That will drive markets up from this setbackApple shares fell on cautious outlook from executives Tesla reported less-than-expected earnings and record sales, mixed results that disappointed investors Facebook warned of “significant uncertainty” on the virus front in 2021, officials in the U.K announced new rules to curb the spread of Covid-19, and Germany lowered its forecast for economic growth in 2021 The European Union was unable to resolve its dispute with AstraZeneca Plc over vaccine supplies, increasing the risk of additional delays in the bloc’s sluggish vaccination campaign Elsewhere, Bitcoin fell below 30$ 000 before the decline was mitigated The euro held losses following comments from a European Central Bank official who said markets are underestimating the chances of a rate cut These are some key events coming up in the coming week: fourth quarter GDP, initial jobless claims and new home sales belong to the USAS Data publications ThursdayUS. Personal Income, Spending and Home Sales Coming FridayThese are the key moves in the markets: StocksS&P 500 futures fell 02% from 10:14 am in Tokyo The display fell 26% on Wednesday Japan’s Topix index was down 1.1% in South Korea Kospi fell 12% Australian S&P / ASX 200 index fell 22% Euro Stoxx 50 futures were 04% lowerCurrencies The Bloomberg Dollar Spot Index rose 01% over the euro fell 01% to USD12094, the yen slid 02% to 10430 pro Dollar Offshore Yuan was 65,058 per dollar, down 02% Bonds 10-year government bond yield was 102% Australia’s 10-year yield was about 109% Commodities West Texas Intermediate Crude Oil slipped 05% to $ 5257 a barrel Gold slipped 04% on 1For more items like this, please visit us on BloombergcomSubscribe now to stay ahead of the game with the most trusted business news source © 2021 Bloomberg LP

Victorian Prime Minister Daniel Andrews says there is “no place for anti-Semitism” after a group of right-wing extremists gathered in Grampians National Park

ASX News

World News – AU – ASX opens lower as “unnatural, crazy” activity overtakes markets